Evidence map›Paper›PMID 33809901›Full record

ArticlePharmaceutics2021

Bactericidal Properties of Rod-, Peanut-, and Star-Shaped Gold Nanoparticles Coated with Ceragenin CSA-131 against Multidrug-Resistant Bacterial Strains.

Sylwia Joanna Chmielewska, Karol Skłodowski, Joanna Depciuch, Piotr Deptuła, Ewelina Piktel, Krzysztof Fiedoruk, Patrycja Kot, Paulina Paprocka, Kamila Fortunka, Tomasz Wollny and 4 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Pharmaceutics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Nosocomial Infections and Role of Nanotechnology.Bioengineering (Basel, Switzerland) · 2022
    Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Nanomaterial Shape Influence on Cell Behavior.International journal of molecular sciences · 2021
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 2 countries.

Sylwia Joanna ChmielewskaDepartment of Medical Microbiology and Nanobiomedical Engineering, Medical University of Bialystok, 15-222 Bialystok, Poland.
Karol SkłodowskiDepartment of Medical Microbiology and Nanobiomedical Engineering, Medical University of Bialystok, 15-222 Bialystok, Poland.
Joanna DepciuchInstitute of Nuclear Physics, Polish Academy of Sciences, 31-342 Krakow, Poland.ORCID 0000-0003-0168-1701
Piotr DeptułaDepartment of Medical Microbiology and Nanobiomedical Engineering, Medical University of Bialystok, 15-222 Bialystok, Poland.
Ewelina PiktelDepartment of Medical Microbiology and Nanobiomedical Engineering, Medical University of Bialystok, 15-222 Bialystok, Poland.
Krzysztof FiedorukDepartment of Medical Microbiology and Nanobiomedical Engineering, Medical University of Bialystok, 15-222 Bialystok, Poland.ORCID 0000-0001-7343-8837
Patrycja KotDepartment of Microbiology and Immunology, Institute of Medical Sciences, Collegium Medicum, Jan Kochanowski University in Kielce, 25-365 Kielce, Poland.
Paulina PaprockaDepartment of Microbiology and Immunology, Institute of Medical Sciences, Collegium Medicum, Jan Kochanowski University in Kielce, 25-365 Kielce, Poland.ORCID 0000-0002-3626-8151
Kamila FortunkaDepartment of Microbiology and Immunology, Institute of Medical Sciences, Collegium Medicum, Jan Kochanowski University in Kielce, 25-365 Kielce, Poland.
Tomasz WollnyHoly Cross Cancer Center, Kielce, 25-734 Kielce, Poland.
Przemysław WolakDepartment of Microbiology and Immunology, Institute of Medical Sciences, Collegium Medicum, Jan Kochanowski University in Kielce, 25-365 Kielce, Poland.ORCID 0000-0003-4450-5011
Magdalena Parlinska-WojtanInstitute of Nuclear Physics, Polish Academy of Sciences, 31-342 Krakow, Poland.ORCID 0000-0001-5901-400X
Paul B SavageDepartment of Chemistry and Biochemistry, Brigham Young University, Provo, UT 84602, USA.
Robert BuckiDepartment of Medical Microbiology and Nanobiomedical Engineering, Medical University of Bialystok, 15-222 Bialystok, Poland.ORCID 0000-0001-7664-9226
Medical University of Białystok · PLJan Kochanowski University · PLInstitute of Nuclear Physics, Polish Academy of Sciences · PLBrigham Young University · USHoly Cross University · PL

Funding

Medical University of Białystok as part of the RPOWP 2007-2013 funding, Priority I, Axis 1.1 UDA- RPPD.01.01.00-20-001/15-00Minister of Science and Higher Education under the name "Regional Initiative of Excellence in 2019-2022 024/RID/2018/19Narodowym Centrum Nauki UMO-2018/31/B/NZ6/02476
6 · The paper itself

Abstract

backgroundThe ever-growing number of infections caused by multidrug-resistant (MDR) bacterial strains requires an increased effort to develop new antibiotics. Herein, we demonstrate that a new class of gold nanoparticles (Au NPs), defined by shape and conjugated with ceragenin CSA-131 (cationic steroid antimicrobial), display strong bactericidal activity against intractable superbugs.

methodsFor the purpose of research, we developed nanosystems with rod- (AuR NPs@CSA-131), peanut-(AuP NPs@CSA-131) and star-shaped (AuS NPs@CSA-131) metal cores. Those nanosystems were evaluated against bacterial strains representing various groups of MDR (multidrug-resistant) Gram-positive (MRSA, MRSE, and MLS

resultsAll of the tested nanosystems exerted potent bactericidal activity in a manner resulting in the generation of ROS, followed by damage of the bacterial membranes and the leakage of intracellular content. Notably, the killing action occurred with all of the bacterial strains evaluated, including those known to be drug resistant, and at concentrations that did not impact the growth of host cells.

conclusionsConjugation of CSA-131 with Au NPs by covalent bond between the COOH group from MHDA and NH

Indexed as

Au NPscerageninsCSA-131MDR (multidrug-resistant)nanosystems

Identifiers

PMID33809901
PMCPMC8004255
OpenAlexW3136265923

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.